XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Income Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 370,776 $ 346,030
Expenses:    
Property operating expenses 307,604 286,080
Depreciation and amortization 70,133 64,800
General and administrative 7,568 5,873
Acquisition and certain other transaction related costs 86 93
Impairment of assets 12,142 5,925
Total expenses 397,533 362,771
(Loss) gain on sale of properties (5,874) 1,233
Gains on equity securities, net 0 8,126
Interest and other income 2,237 4,195
Interest expense (57,576) (47,780)
Loss on modification or early extinguishment of debt 0 (1,075)
Income (loss) before income tax benefit and equity in net losses of investees (87,970) (52,042)
Income tax (expense) benefit (187) 31
Equity in net earnings (losses) of investees 1,898 (647)
Net loss (86,259) (52,658)
Rental income    
Revenues:    
Total revenues 62,650 66,438
Residents fees and services    
Revenues:    
Total revenues 308,126 279,592
Operating Segments | Medical Office and Life Science Portfolio    
Revenues:    
Total revenues 54,149 57,022
Expenses:    
Property operating expenses 23,897 23,515
Depreciation and amortization 20,740 20,035
General and administrative 0 0
Acquisition and certain other transaction related costs 0 0
Impairment of assets 12,142 2,308
Total expenses 56,779 45,858
(Loss) gain on sale of properties (5,874) 0
Gains on equity securities, net 0 0
Interest and other income 0 0
Interest expense (222) (109)
Loss on modification or early extinguishment of debt   0
Income (loss) before income tax benefit and equity in net losses of investees (8,726) 11,055
Income tax (expense) benefit 0 0
Equity in net earnings (losses) of investees 1,613 (647)
Net loss (7,113) 10,408
Operating Segments | SHOP    
Revenues:    
Total revenues 308,126 279,592
Expenses:    
Property operating expenses 283,416 262,329
Depreciation and amortization 46,922 42,152
General and administrative 0 0
Acquisition and certain other transaction related costs 0 0
Impairment of assets 0 3,617
Total expenses 330,338 308,098
(Loss) gain on sale of properties 0 1,233
Gains on equity securities, net 0 0
Interest and other income 0 0
Interest expense (68) (271)
Loss on modification or early extinguishment of debt   0
Income (loss) before income tax benefit and equity in net losses of investees (22,280) (27,544)
Income tax (expense) benefit 0 0
Equity in net earnings (losses) of investees 0 0
Net loss (22,280) (27,544)
Operating Segments | Rental income | Medical Office and Life Science Portfolio    
Revenues:    
Total revenues 54,149 57,022
Operating Segments | Rental income | SHOP    
Revenues:    
Total revenues 0 0
Operating Segments | Residents fees and services | Medical Office and Life Science Portfolio    
Revenues:    
Total revenues 0 0
Operating Segments | Residents fees and services | SHOP    
Revenues:    
Total revenues 308,126 279,592
Non-Segment    
Revenues:    
Total revenues 8,501 9,416
Expenses:    
Property operating expenses 291 236
Depreciation and amortization 2,471 2,613
General and administrative 7,568 5,873
Acquisition and certain other transaction related costs 86 93
Impairment of assets 0 0
Total expenses 10,416 8,815
(Loss) gain on sale of properties 0 0
Gains on equity securities, net 0 8,126
Interest and other income 2,237 4,195
Interest expense (57,286) (47,400)
Loss on modification or early extinguishment of debt   (1,075)
Income (loss) before income tax benefit and equity in net losses of investees (56,964) (35,553)
Income tax (expense) benefit (187) 31
Equity in net earnings (losses) of investees 285 0
Net loss (56,866) (35,522)
Non-Segment | Rental income    
Revenues:    
Total revenues 8,501 9,416
Non-Segment | Residents fees and services    
Revenues:    
Total revenues $ 0 $ 0